A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(48 sites)

United States

Alkermes Investigator Site, Cullman, Alabama

Alkermes Investigator Site, Phoenix, Arizona

Alkermes Investigator Site, Little Rock, Arkansas

Alkermes Investigator Site, Los Angeles, California

Alkermes Investigator Site, Redwood City, California

Alkermes Investigator Site, San Francisco, California

Alkermes Investigator Site, Colorado Springs, Colorado

Alkermes Investigator Site, Brandon, Florida

Alkermes Investigator Site, Miami, Florida

Alkermes Investigator Site, Winter Park, Florida

Alkermes Investigator Site, Atlanta, Georgia

Alkermes Investigator Site, Macon, Georgia

Alkermes Investigator Site, Stockbridge, Georgia

Alkermes Investigator Site, Peoria, Illinois

Alkermes Investigator Site, Kansas City, Kansas

Alkermes Investigator Site, Lansing, Michigan

Alkermes Investigator Site, Lincoln, Nebraska

Alkermes Investigator Site, Middletown, New Jersey

Alkermes Investigator Site, Denver, North Carolina

Alkermes Investigator Site, Huntersville, North Carolina

Alkermes Investigator Site, Canton, Ohio

Alkermes Investigator Site, Cincinnati, Ohio

Alkermes Investigator Site, Cleveland, Ohio

Alkermes Investigator Site, Danville, Pennsylvania

Alkermes Investigator Site, Philadelphia, Pennsylvania

Alkermes Investigator Site, Wyomissing, Pennsylvania

Alkermes Investigator Site, Columbia, South Carolina

Alkermes Investigator Site, Austin, Texas

Alkermes Investigator Site, San Antonio, Texas

Alkermes Investigator Site, Sugar Land, Texas

Alkermes Investigator Site, Sugarland, Texas

Alkermes Investigator Site, Madison, Wisconsin

Australia

Alkermes Investigator Site, Sydney, New South Wales

Alkermes Investigator Site, Bedford Park, South Australia

Alkermes Investigator Site, Clayton, Victoria

Belgium

Alkermes Investigator Site, Alken

Alkermes Investigator Site, Namur

Czechia

Alkermes Investigator Site, Prague

France

Alkermes Investigator Site, Bordeaux, Gironde

Alkermes Investigator Site, Montpellier, Herault

Alkermes Investigator Site, Grenoble, Isere

Italy

Alkermes Investigator Site, Bologna

Alkermes Investigator Site, Milan

Alkermes Investigator Site, Verona

Netherlands

Alkermes Investigator Site, Zwolle

Spain

Alkermes Investigator Site, Barcelona

Alkermes Investigator Site, Madrid

View full record on ClinicalTrials.gov